Allowed patent concerns RemeOs(TM) magnesium-calcium-zinc alloy composition for orthopedic implants[1]. The patent also includes the usage of the RemeOs(TM) magnesium alloy in the manufacturing of orthopedic implants or a part of such implants for all patient populations. The patented magnesium alloy material is used in Bioretec's RemeOs(TM) trauma screws and forthcoming pipeline products.
Bioretec is now moving forward with the application process for this allowed patent to an international PCT application covering regions outside of
"The allowance of this patent for RemeOs(TM) biodegradable metal composition in the
Further enquiries
Certified adviser
Bioretec in brief
Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.
Bioretec is developing the new RemeOs(TM) product line based on a magnesium alloy and hybrid composite, introducing a new generation of strong biodegradable materials for enhanced surgical outcomes. The RemeOs(TM) implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their
Better healing - Better life. www.bioretec.com
[1] Magnesium alloy with Ca in the range of 0.550-0.700 weight-% and Zn in the range of 0.400 - 0.700 weight-%
https://news.cision.com/bioretec/r/inside-information--bioretec-s-remeos--biodegradable-magnesium-alloy-composition-has-been-allowed-a-,c3950170
(c) 2024 Cision. All rights reserved., source